Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J De Cree

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Clinical Rheumatology|September 1, 1982
Enumeration of T-lymphocytes and T-lymphocyte subsets in rheumatoid arthritis using monoclonal antibodiesF Raeman, W De Cock, T De Beukelaar, et al.
Lancet (London, England)|April 26, 1975
Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's diseaseH Verhaegen, W De Cock, J De Cree, et al.
Arzneimittel-Forschung|June 1, 1988
Absorption, metabolism and excretion of ketanserin in man after oral administrationW Meuldermans, J Hendrickx, R Woestenborghs, et al.
Blood|November 1, 1978
Purine nucleoside phosphorylase in chronic lymphocytic leukemia (CLL)M Borgers, H Verhaegen, M De Brabander, et al.
Acta Paediatrica Belgica|October 1, 1978
Chronic salmonella infection with hypergammaglobulinemic purpura and cryoglobulinemia in a five year old girlM Alexander, C Bieva, J P Butzler, et al.
European Journal of Cancer|June 1, 1977
The effects of R U7934 (NSC 238159), a new antimicrotubular substance, on the ultrastructure of neoplastic cells in vivoM De Brabander, G Geuens, R Van De Veire, et al.
Journal of Cardiovascular Pharmacology|May 1, 1988
Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonistA Van de Water, W Janssens, J Van Neuten, et al.
Experientia|December 15, 1977
Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediatorsF Awouters, C J Niemegeers, J Van den Berk, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Rheumatology|September 1, 1982
Enumeration of T-lymphocytes and T-lymphocyte subsets in rheumatoid arthritis using monoclonal antibodiesF Raeman, W De Cock, T De Beukelaar, et al.
Lancet (London, England)|April 26, 1975
Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's diseaseH Verhaegen, W De Cock, J De Cree, et al.
Arzneimittel-Forschung|June 1, 1988
Absorption, metabolism and excretion of ketanserin in man after oral administrationW Meuldermans, J Hendrickx, R Woestenborghs, et al.
Blood|November 1, 1978
Purine nucleoside phosphorylase in chronic lymphocytic leukemia (CLL)M Borgers, H Verhaegen, M De Brabander, et al.
Acta Paediatrica Belgica|October 1, 1978
Chronic salmonella infection with hypergammaglobulinemic purpura and cryoglobulinemia in a five year old girlM Alexander, C Bieva, J P Butzler, et al.
European Journal of Cancer|June 1, 1977
The effects of R U7934 (NSC 238159), a new antimicrotubular substance, on the ultrastructure of neoplastic cells in vivoM De Brabander, G Geuens, R Van De Veire, et al.
Journal of Cardiovascular Pharmacology|May 1, 1988
Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonistA Van de Water, W Janssens, J Van Neuten, et al.
Experientia|December 15, 1977
Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediatorsF Awouters, C J Niemegeers, J Van den Berk, et al.
Pageof 5